Resalis Therapeutics
Resalis Therapeutics is dedicated to developing RNA-based therapies that tackle the root causes of complex metabolic disorders.
$10.92M Series A ·
Source: startupintros.com
Total raised: $21.56M across 2 sourced rounds
All 2 rounds ↓Signals
Website registeredFeb 3, 2021 (5 years old)
Funding rounds
- Series A · $10.92MSource: startupintros.com
- Seed · $10.64MSource: startupintros.com
- Website created
Founders and team
- RPRiccardo Panella Chief Scientific Officer & Co-Foundersource: resalistherapeutics.com
- SKSakari Kauppinen Chief Technology Officer & Co-Foundersource: resalistherapeutics.com
Companies like Resalis Therapeutics
RReRx
VVico Therapeutics$71M Series B+ · Jun 2024
AArnatar Therapeutics$50M Series A · Mar 2026
EEnthea$2M Seed · Dec 2022AAzafaros$150M Series B+ · May 2025
UUndo$37M · Jun 2026
Sources and API
Every amount links to the page it came from. * Estimated from an accelerator's published standard deal, not a company-specific disclosure. How Recent Funding sources and verifies funding data. The same data as JSON: /api/v1/companies/resalis-therapeutics (get a free API key).